Hwang Hae-Gwang, Kim Dae-Hwan, Lee Jeongmin, Mo Youngwon, Lee Se-Hoon, Lee Yongjin, Hyeon Jae Wook, Lee Sol Moe, Cheon Yong-Pil, Choi Eun-Kyoung, Kim Su Yeon, Lee Yeong Seon, Son Young-Jin, Ryou Chongsuk
Department of Pharmacy, Sunchon National University, Suncheon 57922, Republic of Korea.
Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University, Ansan 15588, Republic of Korea.
J Microbiol Biotechnol. 2018 Oct 28;28(10):1749-1759. doi: 10.4014/jmb.1805.05067.
Recombinant (rec) prion protein (PrP) is an extremely useful resource for studying protein misfolding and subsequent protein aggregation events. Here, we report mass production of high-purity rec-polypeptide encoding the C-terminal globular domain of PrP; (90-230) for human and (89-231) for murine PrP. These proteins were expressed as His-tagged fusion proteins in cultured by a high cell-density aerobic fermentation method. RecPrPs recovered from inclusion bodies were slowly refolded under reducing conditions. Purification was performed by a sequence of metal-affinity, cation-exchange, and reverse-phase chromatography. The current procedure yielded several dozens of milligrams of recPrP per liter with >95% purity. The purified recPrPs predominantly adopted an α-helix-rich conformation and were functionally sufficient as substrates to measure the seeding activity of human and animal prions. Establishment of a procedure for high-level production of high-purity recPrP supports the advancement of in vitro investigations of PrP including diagnosis for prion diseases.